Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

TNA vs LABU: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TNA Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–0 Matrix Metrics)

TNA Overall Winner 6-Pillar Tally: TNA 0 – 0 LABU (6 Tie) Matrix Metrics: TNA 2 – 0 LABU

As of Nov 16, 2026, Direxion Daily Small Cap Bull 3x Shares (TNA) is the stronger overall head-to-head candidate over Direxion Daily S&P Biotech Bull 3X Shares (LABU) in the Tradestie Institutional Equity Comparison Engine, winning 2–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). TNA carries a Unified Composite Score of 49.5/100 (HOLD) at $52.96 (N/M Forward P/E, N/A operating margin), whereas LABU carries 49.4/100 (HOLD) at $195.22 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: TNA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.2); meanwhile LABU is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TNA vs LABU
TNA NYSE Arca Head-to-Head Winner
Direxion Daily Small Cap Bull 3x Shares
Institutional Equity
$52.96
-4.97% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 3.27β · 75% Vol
Unified Composite Score
49.5 / 100 HOLD
Tech 25.0 Fund 41.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.5%), weak momentum, RSI 41
RSI-14: 41.2 · SMA20: $56.96 · SMA50: $58.81
LABU NYSE Arca
Direxion Daily S&P Biotech Bull 3X Shares
Institutional Equity
$195.22
-9.13% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 3.71β · 119% Vol
Unified Composite Score
49.4 / 100 HOLD
Tech 25.0 Fund 39.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.3%), weak momentum, RSI 40
RSI-14: 40.4 · SMA20: $232.97 · SMA50: $242.77

6-Pillar Scorecard Institutional Category Breakdown (TNA 0 – 0 LABU)

Columns: Metric · TNA · LABU
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 49.8% (36th %ile) 86.4% (12th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TNA (2) vs LABU (0)
Institutional Metric TNA LABU Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
40% ($37–$77) 33% ($124–$342) Stronger Trend TNA
Beta / 30D Volatility
Risk Regime
3.27β · 75% Vol 3.71β · 119% Vol Lower Realized Risk TNA
Unified Institutional Score
Composite Signal
49.5 / 100 (HOLD) 49.4 / 100 (HOLD) Higher Composite Tie
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon TNA +2.3 pp
TNA: +0.47% · LABU: -1.83%
3M Horizon TNA +4.73 pp
TNA: -27.95% · LABU: -32.68%
6M Horizon LABU +32.37 pp
TNA: -10.83% · LABU: +21.54%
1Y Horizon LABU +25.43 pp
TNA: +28.54% · LABU: +53.97%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TNA vs LABU. Trailing 12-month operating profitability (TNA N/A vs LABU N/A) and valuation multiples (TNA N/M vs LABU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

TNA ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
LABU ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TNA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 49.8%
IV Percentile 36th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TNA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LABU UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 86.4%
IV Percentile 12th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact LABU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TNA Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
LABU Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ TNA vs LABU Key Questions & Quantitative Answers

As of Nov 16, 2026, Direxion Daily Small Cap Bull 3x Shares (TNA) is the stronger overall head-to-head candidate over Direxion Daily S&P Biotech Bull 3X Shares (LABU) in the Tradestie Institutional Equity Comparison Engine, winning 2–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). TNA carries a Unified Composite Score of 49.5/100 (HOLD) at $52.96 (N/M Forward P/E, N/A operating margin), whereas LABU carries 49.4/100 (HOLD) at $195.22 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: TNA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.2); meanwhile LABU is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

TNA and LABU split Growth & Scale metrics: TNA posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with LABU at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, TNA generates N/A in USD-normalized revenue versus N/A for LABU. In operating R&D and SG&A reinvestment, TNA deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for LABU.

TNA and LABU trade at balanced relative valuation multiples. TNA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas LABU trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TNA (N/A ROE) versus LABU (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, TNA carries 49.8% implied volatility (36th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.27β · 75% Vol realized risk). By comparison, LABU carries 86.4% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.71β · 119% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.